This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris, National Institute of Health and Medical Research. Active years: 2025.
Company Filing History:
1 out of 5,383 
1 out of 105 
1 out of 1,853 
Years Active: 2025
Title: Decio Laks Eizirik: Innovator in Diabetes Research
Introduction
Decio Laks Eizirik is a prominent inventor based in Brussels, Belgium. He has made significant contributions to the field of diabetes research, particularly in the development of diagnostic and therapeutic methods for Type 1 diabetes. His innovative work has garnered attention in the scientific community.
Latest Patents
Eizirik holds a patent titled "Antigenic Peptides Deriving from Secretogranin V and Uses Thereof for the Diagnosis and Treatment of Type 1 Diabetes." This patent represents a crucial advancement in understanding and potentially treating this chronic condition. He has 1 patent to his name.
Career Highlights
Throughout his career, Eizirik has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Paris. His research has focused on the mechanisms underlying Type 1 diabetes and the development of novel therapeutic strategies.
Collaborations
Eizirik has collaborated with notable colleagues, including Roberto Mallone and Joëlle Vinh. These partnerships have enhanced his research efforts and contributed to the advancement of diabetes treatment.
Conclusion
Decio Laks Eizirik is a key figure in diabetes research, with a focus on innovative solutions for Type 1 diabetes. His contributions through patents and collaborations continue to impact the field positively.